Voyager Therapeutics, Inc.
COMPOSITIONS AND METHODS FOR DELIVERY OF AAV
Last updated:
Abstract:
The disclosure provides compositions and methods for the preparation, manufacture, formulation and therapeutic use of adeno-associated virus (AAV) particles for the prevention and/or treatment of diseases.
Status:
Application
Type:
Utility
Filling date:
15 May 2019
Issue date:
29 Jul 2021